MDEA: Difference between revisions
>Unity |
>Unity mNo edit summary |
||
Line 122: | Line 122: | ||
As with other [[stimulant]]s, the chronic use of MDEA can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | As with other [[stimulant]]s, the chronic use of MDEA can be considered [[Addiction potential::moderately addictive with a high potential for abuse]] and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and [[withdrawal effects]] may occur if a person suddenly stops their usage. | ||
Tolerance to many of the effects of MDEA develops [[Time to full tolerance::with prolonged and repeated use]]. This results in users having to administer increasingly larger doses to achieve the same effects. After that, it takes about [[Time to half tolerance::1 months]] for the tolerance to be reduced to half and [[Time to zero tolerance::2-3 months]] to be back at baseline (in the absence of further consumption). MDEA presents cross-tolerance with [[Cross-tolerance::all [[dopamine]]rgic and [[serotonin|serotonergic]] [[stimulant]]s and entactogens, meaning that after the consumption of MDEA all | Tolerance to many of the effects of MDEA develops [[Time to full tolerance::with prolonged and repeated use]]. This results in users having to administer increasingly larger doses to achieve the same effects. After that, it takes about [[Time to half tolerance::1 months]] for the tolerance to be reduced to half and [[Time to zero tolerance::2-3 months]] to be back at baseline (in the absence of further consumption). MDEA presents cross-tolerance with [[Cross-tolerance::all [[dopamine]]rgic and [[serotonin|serotonergic]] [[stimulant]]s and entactogens]], meaning that after the consumption of MDEA all of these will have a reduced effect. | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||
Line 130: | Line 130: | ||
*'''[[DangerousInteraction::Stimulants]]''' - The neurotoxic effects of MDEA may be increased when combined with other stimulants. | *'''[[DangerousInteraction::Stimulants]]''' - The neurotoxic effects of MDEA may be increased when combined with other stimulants. | ||
*'''[[DangerousInteraction::Cocaine]]''' - This combination may increase strain on the heart. | *'''[[DangerousInteraction::Cocaine]]''' - This combination may increase strain on the heart. | ||
====[[Serotonin syndrome]] risk==== | ====[[Serotonin syndrome]] risk==== | ||
{{DangerousInteractions/SerotoninSyndrome}} | {{DangerousInteractions/SerotoninSyndrome}} | ||
Line 147: | Line 148: | ||
*[[Entactogens]] | *[[Entactogens]] | ||
*[[Stimulants]] | *[[Stimulants]] | ||
*[[ | *[[Phenethylamine]] | ||
*[[Amphetamines]] | *[[Amphetamines]] | ||
*[[MDMA]] | *[[MDMA]] | ||
*[[MDA]] | *[[MDA]] | ||
*[[MDAI]] | *[[MDAI]] | ||
==External links== | ==External links== | ||
*[http://en.wikipedia.org/wiki/MDEA MDEA (Wikipedia)] | *[http://en.wikipedia.org/wiki/MDEA MDEA (Wikipedia)] | ||
Line 162: | Line 164: | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Amphetamine]] | [[Category:Amphetamine]] | ||
[[Category: | [[Category:Phenethylamine]] | ||
[[Category:Entactogen]] | [[Category:Entactogen]] | ||
{{#set:Featured=false}} | {{#set:Featured=false}} |